Russell Investments Group, Ltd. Corbus Pharmaceuticals Holdings, Inc. Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$1.27 - $3.42 $17,907 - $48,222	-14,100 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$0.94 - $1.89 $274,708 - $552,339	-292,243 Reduced 95.4%	14,100 $17,000
Q3 2020 Nov 09, 2020	SELL	$1.5 - $9.38 $6,880 - $43,026	-4,587 Reduced 1.48%	306,343 $551,000
Q2 2020 Aug 05, 2020	BUY	$4.79 - $8.39 $272,167 - $476,719	56,820 Added 22.36%	310,930 $2.61 Million
Q1 2020 May 06, 2020	BUY	$3.44 - $7.21 $124,359 - $260,648	36,151 Added 16.59%	254,110 $1.33 Million
Q3 2019 Nov 01, 2019	BUY	$4.87 - $7.08 $1.06 Million - $1.54 Million	217,959 New	217,959 $1.06 Million

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $724M
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.